Antipyretic/Analgesics Are Most Common Cause for Relief Benefits for Damage from ADRs: PMDA

June 25, 2012
According to a report compiled by the Pharmaceuticals and Medical Devices Agency (PMDA), antipyretic analgesics were the most common cause for relief benefits for damage from adverse drug reactions (ADRs) by therapeutic category in the five consecutive years from FY2007...read more